TABLE 1.
Site of Recurrence (n = 125 Patients)*
| Choline-Positive Lesions (n = 93 Patients) | n (%) |
|---|---|
| LR | 19 (20%) |
| LN | 42 (45%) |
| Bone | 13 (14%) |
| LR and LN | 4 (4%) |
| LR and bone | 2 (2%) |
| LN and bone | 7 (8%) |
| LR, LN, and bone | 2 (2%) |
| Distant metastases | 4 (4%) |
| PSMA-positive lesions (n = 14/32 patients) | |
| LR | 8 (57%) |
| LN | 6 (43%) |
*
Patients, who refused additional 68Ga-PSMA-PET/CT (n = 9) and patients with equivocal findings (n = 5) were excluded. LR indicates local recurrence; LN, lymph node metastases; bone, bone metastases.